Inetetamab Combined With Paclitaxel With/Without Pertuzumab for Previously Treated HER2-positive Advanced Breast Cancer
NCT06578299
·
clinicaltrials.gov ↗
PHASE4
Phase
NOT_YET_RECRUITING
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer Stage IV
Interventions
DRUG:
Inetetamab and Paclitaxel ± Pertuzumab
Sponsor
Fudan University